Myelodysplastic Syndrome Clinical Trial

Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study

Summary

How does long term treatment with Soliris affect HAHA in PNH patients?

View Full Description

Full Description

To determine the long term effect of Soliris (eculizumab) treatment on the presence of human anti-human antibodies (HAHA) in Paroxysmal Nocturnal Hemoglobinuria (PNH) patients.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

PNH patients who previously participated in study E05-001;
Patients who have an eculizumab naive serum sample for comparison;
Patients who currently used commerical Soliris;
Patients who are willing and able to gie written informed consent.

Exclusion Criteria:

There are no exclusion criteria for this study.

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

75

Study ID:

NCT01412047

Recruitment Status:

Completed

Sponsor:

Alexion Pharmaceuticals

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

University Park Hematology Oncology
Englewood Colorado, 80113, United States
Cleveland Clinic Florida
Weston Florida, 33331, United States
Maine Cancer Center of Medicine
Scarborough Maine, 04074, United States

Melbourne , , Australia

Brussels , , Belgium

Paris , , France
Universitatsklinikum Essen
Essen , , Germany
Institut fur Klinische Transfusionmedizin und Immungenetick
Ulm , , Germany

Dublin , , Ireland
Azienda Ospediliera Universitatia Careggi
Firenze , , Italy
Universita degli Studi di Napoli
Napoli , , Italy

Nijmegen , , Netherlands

Basel , , Switzerland

London , , United Kingdom

How clear is this clinincal trial information?

Study is for people with:

Myelodysplastic Syndrome

Estimated Enrollment:

75

Study ID:

NCT01412047

Recruitment Status:

Completed

Sponsor:


Alexion Pharmaceuticals

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider